These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A phase I study of paclitaxel, UFT, and leucovorin. Gojo I; Tkaczuk KH Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):76-8. PubMed ID: 11098500 [TBL] [Abstract][Full Text] [Related]
4. A phase I study. UFT/leucovorin combined with paclitaxel for anthracycline-pretreated advanced breast cancer. Scholz U; Lück HJ; Canzler U; Robner D; Kühnle H Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):44-6. PubMed ID: 11098492 [TBL] [Abstract][Full Text] [Related]
5. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U; Wilke H; Seeber S Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [TBL] [Abstract][Full Text] [Related]
6. A phase I study of oral uracil-ftorafur plus folinic acid in combination with weekly paclitaxel in patients with solid tumors. Mayer F; Hartmann JT; von Pawel J; Beck J; Schroeder M; Boehlke I; Kanz L; Bokemeyer C; Ann Oncol; 2002 May; 13(5):755-9. PubMed ID: 12075745 [TBL] [Abstract][Full Text] [Related]
7. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma. Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517 [TBL] [Abstract][Full Text] [Related]
8. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma. Pazdur R; Lassere Y; Rhodes V; Ajani JA; Sugarman SM; Patt YZ; Jones DV; Markowitz AB; Abbruzzese JL; Bready B J Clin Oncol; 1994 Nov; 12(11):2296-300. PubMed ID: 7964943 [TBL] [Abstract][Full Text] [Related]
9. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule. Pazdur R; Lassere Y; Diaz-Canton E; Ho DH Cancer Invest; 1998; 16(3):145-51. PubMed ID: 9541627 [TBL] [Abstract][Full Text] [Related]
10. Irinotecan and UFT/leucovorin in patients with advanced cancers. Stevenson JP; Redlinger M; Sun W; Haller D; O'Dwyer PJ Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):91-2. PubMed ID: 11098504 [TBL] [Abstract][Full Text] [Related]
11. A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3-times-daily regimen to treat patients with recurrent metastatic breast cancer. Hortobagyi GN; Heim W; Hutchins L; Rivera E; Mason B; Booser DJ; Kirshner J Cancer; 2010 Mar; 116(6):1440-5. PubMed ID: 20091835 [TBL] [Abstract][Full Text] [Related]
13. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 14-day schedule. Pazdur R; Lassere Y; Diaz-Canton E; Bready B; Ho DH Invest New Drugs; 1997; 15(2):123-8. PubMed ID: 9220291 [TBL] [Abstract][Full Text] [Related]
14. A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma. Czito BG; Cohen DP; Kelsey CR; Lockhart AC; Bendell JC; Willett CG; Petros WP; D'Amico TA; Truax R; Hurwitz HI Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1066-72. PubMed ID: 17881149 [TBL] [Abstract][Full Text] [Related]
15. A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer. Hortobagyi GN; Young RR; Karwal M; Ibrahim NK; Hermann R; Murray JL; Watkins SP; Gore I Cancer; 2010 May; 116(10):2301-6. PubMed ID: 20225231 [TBL] [Abstract][Full Text] [Related]
16. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis. Klaassen U; Wilke H; Pari CP; Strumberg D; Harstrick A; Eberhardt W; Becher R; Diergarten K; Seeber S Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancer. Klaassen U; Borquez D; Lang S; Oberhoff C; Harstrick A; Seeber S; Benner S Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):71-3. PubMed ID: 10442367 [TBL] [Abstract][Full Text] [Related]
18. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group. Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994 [TBL] [Abstract][Full Text] [Related]
19. A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer. Lin CC; Cheng AL; Hsu CH; Lu YS; Hsu C; Yeh KH; Wu CY; Huang CS; Yang CH Anticancer Res; 2007; 27(1B):641-5. PubMed ID: 17348454 [TBL] [Abstract][Full Text] [Related]
20. Phase I study of paclitaxel and uracil plus tegafur combination in patients with pretreated metastatic breast cancer: drug sequencing based on preclinical modelling studies. Passardi A; Maltoni R; Milandri C; Cecconetto L; Massa I; Zoli W; Tesei A; Fabbri F; Nanni O; Amadori D Oncology; 2007; 72(1-2):118-24. PubMed ID: 18004083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]